SEP 10, 2026 · PHASE 1 TRIAL
Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic Cancer
ClinicalTrials.gov
Phase 1 dose-escalation trial with 29 enrolled participants testing safety and maximum tolerated dose; no efficacy results reported in this registry record.
Reported
Planned enrollment29
PhasePhase 1
Primary outcome: Maximum Tolerate…Up to 21 days (first treatment cycle)